Literature DB >> 10485878

Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

M A Argiriadi1, C Morisseau, B D Hammock, D W Christianson.   

Abstract

The crystal structure of recombinant murine liver cytosolic epoxide hydrolase (EC 3.3.2.3) has been determined at 2.8-A resolution. The binding of a nanomolar affinity inhibitor confirms the active site location in the C-terminal domain; this domain is similar to that of haloalkane dehalogenase and shares the alpha/beta hydrolase fold. A structure-based mechanism is proposed that illuminates the unique chemical strategy for the activation of endogenous and man-made epoxide substrates for hydrolysis and detoxification. Surprisingly, a vestigial active site is found in the N-terminal domain similar to that of another enzyme of halocarbon metabolism, haloacid dehalogenase. Although the vestigial active site does not participate in epoxide hydrolysis, the vestigial domain plays a critical structural role by stabilizing the dimer in a distinctive domain-swapped architecture. Given the genetic and structural relationships among these enzymes of xenobiotic metabolism, a structure-based evolutionary sequence is postulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485878      PMCID: PMC17935          DOI: 10.1073/pnas.96.19.10637

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  The Cationminus signpi Interaction.

Authors:  Jennifer C. Ma; Dennis A. Dougherty
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  The alpha/beta hydrolase fold.

Authors:  D L Ollis; E Cheah; M Cygler; B Dijkstra; F Frolow; S M Franken; M Harel; S J Remington; I Silman; J Schrag
Journal:  Protein Eng       Date:  1992-04

3.  Raster3D Version 2.0. A program for photorealistic molecular graphics.

Authors:  E A Merritt; M E Murphy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-11-01

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  Methods used in the structure determination of bovine mitochondrial F1 ATPase.

Authors:  J P Abrahams; A G Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1996-01-01

6.  Crystallographic R factor refinement by molecular dynamics.

Authors:  A T Brünger; J Kuriyan; M Karplus
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

7.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

Authors:  C Morisseau; M H Goodrow; D Dowdy; J Zheng; J F Greene; J R Sanborn; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  The x-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1. An enzyme to detoxify harmful epoxides.

Authors:  M Nardini; I S Ridder; H J Rozeboom; K H Kalk; R Rink; D B Janssen; B W Dijkstra
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

9.  Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols.

Authors:  E C Dietze; E Kuwano; J Casas; B D Hammock
Journal:  Biochem Pharmacol       Date:  1991-08-22       Impact factor: 5.858

10.  An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase.

Authors:  M Arand; M Knehr; H Thomas; H D Zeller; F Oesch
Journal:  FEBS Lett       Date:  1991-12-02       Impact factor: 4.124

View more
  65 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

2.  Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site.

Authors:  Michael Arand; B Martin Hallberg; Jinyu Zou; Terese Bergfors; Franz Oesch; Mariët J van der Werf; Jan A M de Bont; T Alwyn Jones; Sherry L Mowbray
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

3.  Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.

Authors:  Shao-Xu Huang; Hui-Yuan Li; Jun-Yan Liu; Christophe Morisseau; Bruce D Hammock; Ya-Qiu Long
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

4.  X-ray structure of potato epoxide hydrolase sheds light on substrate specificity in plant enzymes.

Authors:  Sherry L Mowbray; Lisa T Elfström; Kerstin M Ahlgren; C Evalena Andersson; Mikael Widersten
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

5.  EHPred: an SVM-based method for epoxide hydrolases recognition and classification.

Authors:  Jia Jia; Liang Yang; Zi-Zhang Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2006-01       Impact factor: 3.066

6.  Coupling between catalytic site and collective dynamics: a requirement for mechanochemical activity of enzymes.

Authors:  Lee-Wei Yang; Ivet Bahar
Journal:  Structure       Date:  2005-06       Impact factor: 5.006

7.  Outliers in SAR and QSAR: is unusual binding mode a possible source of outliers?

Authors:  Ki Hwan Kim
Journal:  J Comput Aided Mol Des       Date:  2007-03-03       Impact factor: 3.686

8.  Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.

Authors:  German A Gomez; Christophe Morisseau; Bruce D Hammock; David W Christianson
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

9.  The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase.

Authors:  Annette Cronin; Sherry Mowbray; Heike Dürk; Shirli Homburg; Ingrid Fleming; Beate Fisslthaler; Franz Oesch; Michael Arand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

10.  The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity.

Authors:  John W Newman; Christophe Morisseau; Todd R Harris; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.